Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 62 for “"Adoptive immunotherapy"”.
-
CYTOKINE-ACTIVATED γδ T CELLS IN ADOPTIVE IMMUNOTHERAPY
γδT cells are promising candidates for cellular immunotherapy due to their immune regulation through cytokine production and MHC-independent cytotoxicity against tumours. However, current γδT cell-based cancer immunotherapy has limited efficacies and novel strategies are needed to improve its …
-
Active and Adoptive Immunotherapy in Indolent Lymphoproliferative Diseases
… its maintenance and progression suggests that immunotherapy may represent a valuable strategy towards the control and eradication of these malignancies. Despite initial successes of anti-idiotype vaccination, its clinical benefits have not been definitely proven. New insights into the …
-
Adoptive Immunotherapy with Interleukin-2 : Current Status and Nursing Assessment
… DNA biotechnology have led to the development of adoptive immunotherapy, the transfer of immunologic cells with antitumor reactivity to the cancer patient (Rosenberg, 1984). The purpose of this essay is to review the current status of adoptive immunotherapy with interleukin-2 (IL-2) and to examine …
-
Cellular and Molecular Aspects Of Naïve T cell Priming for Adoptive Immunotherapy
Over the past decade immunotherapy has emerged as a powerful tool in the treatment of advanced cancer and recurrent viral diseases. In particular, clinical success with Immune Checkpoint Blockade has led to the rapid approval of immunomodulating drugs for the treatment of metastatic cancers. …
-
Regulatory T cells in adoptive immunotherapy: from subset characterization to functional testing
… to predict their fate following application in adoptive tTREG transfer. – Secondly, the development of a yet missing robust and short-term test system for evaluating tTREG-mediated suppressive function as a release criterion for their application in adoptive immunotherapy would facilitate …
-
Isolation and culture of T cell clones for adoptive immunotherapy and epitope discovery
This research project built on previous findings within the host laboratory that naïve CD4+ and CD8+ T cells can be stimulated and maintained in vitro under the influence of the common γc cytokine IL-7 and retain central memory characteristics. Further, this project aimed to expand these …
-
Novel approaches to identify T cell-recognized tumor antigens and to redirect T cells for adoptive immunotherapy
Tumor antigens (Ags) and adoptive immunotherapy are two important topics in tumor immunology. Traditional methods for identifying T cell-recognized tumor antigens and adoptive therapy using antigen-specific T cells are laborious and difficult. Rapid developments in molecular biology and immunology …
-
EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY.
… transgenic mouse model of breast carcinoma upon adoptive immunotherapy (AIT), only when combined with the depletion of endogenous MDSCs. In this study we have introduced a novel formulation of the sequential common gamma chain cytokines (initiation of culture with IL-7 + IL-15 followed by the …
-
AUGMENTATION OF T CELL EXPANSION FOR ADOPTIVE IMMUNOTHERAPY BY ALTERNATE GAMMA CHAIN CYTOKINES AND BY GEMCITABINE MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS
Successful treatment of cancer with adoptive immunotherapy (AIT) is dependent on the ability to produce large numbers of tumor-specific, functional T cells. The purpose of this thesis is to explore ways in which T cell expansion could be augmented. We have focused on exploring alternate gamma chain …
-
Generation and expression of high affinity, tumor antigen-specific mouse and human T cell receptors to genetically modify CD8p+s T cells for adoptive immunotherapy of cancer
Adoptive T cell immunotherapy has shown promise in treating some cancers, but the challenge of isolating T cells with high avidity for tumor antigens limits large-scale applicability. T cell receptor (TCR) gene transfer employing high affinity TCRs recognizing defined tumor-associated antigens can …
-
IL-17 Secreting CD8+ T Cells: Induction, Plasticity and Role in Anti-Tumor Immunity
… IL-17, and are known as Tc17 cells. In mice, adoptive T cell immunotherapy for cancer results in tumor regression and long term survival. In previous work, it was shown that efficacy of Tc17 cell adoptive immunotherapy correlates with Tc17 conversion from IL-17 to IFN-γ production …
-
Optimization of Cryopreserved Memory CD4 T Cell Mediated Protection against Lethal Influenza A Virus Infection in Mice
… of CD4+ T memory cells as a candidate for adoptive immunotherapy, here we validated and optimized cryopreserved IAV-specific memory CD4+ T cell-mediated protection against infection and evaluated their potential for subsequent memory formation. Donor-derived in vitro-generated memory CD4+ T …
-
The Role of Myeloid-Derived Suppressor Cells in the Immunotherapy of Breast Carcinomas
… humans, including HER2/neu+ breast cancers. The adoptive immunotherapy of cancers has been a promising field, yet the clinical efficacy of adoptive immunotherapies targeted against human breast cancers and many other cancers has been extremely limited. Given the influx of MDSC in tumor-bearing …
-
The Crucial Roles of JMJD3 in T Cell Trafficking and Persistence
… Jmjd3 may be a good therapeutic target for adoptive immunotherapy for the generation of superior T cell grafts.
-
Z-Curve: A Time Difference of Arrivals (TDOA) Based Model for Global Navigation Satellite Systems (GNSS) Signals
… Jmjd3 may be a good therapeutic target for adoptive immunotherapy for the generation of superior T cell grafts.
-
MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS
Successful adoptive immunotherapy (AIT) for cancer relies on the infusion of in vitro expanded, tumor-reactive lymphocytes with a goal of generating productive tumor immunity. Previously, our lab has developed a protocol to activate selectively tumor-reactive T lymphocytes in vitro using two …
-
Tethered Il-15 to Augment The Therapeutic Potential of T Cells Expressing Chimeric Antigen Receptor: Maintaining Memory Potential, Persistence, and Antitumor Activity
… potential, persistence, and antitumor activity Adoptive immunotherapy can retarget T cells to CD19, a tumor-associated antigen (TAA) expressed on B-cell malignancies, by the expression of a chimeric antigen receptor (CAR). Infusion of CAR-modified T cells for the treatment B-cell malignancies …
-
Cultivation of Natural Killer Cell for Immunotherapy
… use in promoting NK cells in the field of adoptive immunotherapy.
Page 1 of 4